Worldwide Clinical Trials Brochures

  1. Site Alliances: The Power Of Site Engagement 11/10/2022

    Here at Worldwide Clinical Trials, we created the Site Alliance Collaboration, not just targeting major academic centers, but all types of sites in order to deliver the most efficient trials for our clients.

  2. Make Informed Decisions, Faster 10/5/2022

    For more than 15 years, Worldwide Clinical Trials has been a trusted market leader in bioanalysis. Our scientific heritage not only means we have accessible expertise to work closely with you, but also means we are compulsive about quality.

  3. Adaptive Trial Design — Is It Right For Your Clinical Study? 9/7/2022

    Worldwide Clinical Trials’ extensive adaptive trial knowledge (from protocol design through data collection and analysis) can help you fully realize the potential benefits of adaptive trial design methodology.

  4. How To Know If It’s Time To Bring In A New CRO 7/20/2022

    Learn how Worldwide can help when it's time to transition your study to another CRO.

  5. Reducing Your Phase I Clinical Pharmacology Timelines 7/19/2022

    From faster study set-up timelines to closing project delivery gaps, we help you shorten your Phase I clinical pharmacology timelines.

  6. 5 Reasons For Worldwide’s Impressively Low CRA Turnover (And What That Means For You!) 7/1/2022

    Find out why when CRAs come to Worldwide Clinical Trials, they come to a company that invests in them and supports their growth.

  7. In The Fight To Bring Innovative Therapies To Patients 5/2/2022

    Dive into how Worldwide Clinical Trials delivers an innovative data-driven approach, in-region expertise and operational acumen to ensure on-time delivery for each study.

  8. How To Know If It’s Time To Bring In A New CRO 4/20/2022

    How do you know when it’s time to transition your study to another CRO? It’s a difficult decision, and one that should be considered carefully.

  9. Keeping NDA On Schedule After Unexpected FDA Feedback 4/4/2022

    Gain insight into how five last-minute studies were accommodated, executed, analyzed, and properly documented for the FDA and EMA in just 8 months.

  10. What Do You Need To Run A Phase I In A Rare Disease Patient Population? 3/18/2022

    Learn from Worldwide the key tools needed to run a rare disease Phase I trial.